Stock listing
Rhythm Pharmaceuticals, Inc.
Selected listing: 1RV · GETTEX · EUR · DE
Rhythm Pharmaceuticals, Inc. (gettex:1RV), Health Technology. Latest release Sep 22, 2026: Rhythm Pharmaceuticals Announces Health Canada Approval…
- Ticker
- gettex:1RV
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- gettex
- Currency
- EUR
About Rhythm Pharmaceuticals, Inc.
Rhythm Pharmaceuticals, Inc. (Ticker: RYTM) is a public company based in the United States, specializing in the development of innovative therapies for rare genetic diseases related to obesity. The company's commitment to improving patient outcomes positions it as a key player in the biotechnology sector.
Latest news from Rhythm Pharmaceuticals, Inc.
Rhythm Pharmaceuticals Announces Health Canada Approval of IMCIVREE® (setmelanotide) for Weight Management in Adult and Pediatric Patients 4 years of Age and Older with Acquired Hypothalamic Obesity
September 22, 2026
Rhythm Pharmaceuticals Announces New Data Presentations at the European Society for Paediatric Endocrinology Meeting
September 10, 2026
Rhythm Pharmaceuticals Announces MHLW Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity (HO) in Japan
August 24, 2026
Rhythm Pharmaceuticals Announces Appointment of Manher (AJ) Joshi as Chief Medical Officer
August 17, 2026
Rhythm Pharmaceuticals Announces IMCIVREE® (setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity due to Hypothalamic Injury or Impairment
August 11, 2026
Events
Research Rhythm Pharmaceuticals, Inc.
Rhythm Pharmaceuticals, Inc. company profile
View the public company page for Rhythm Pharmaceuticals, Inc. on 6ix.
Rhythm Pharmaceuticals, Inc. news
Read company news and market updates connected to Rhythm Pharmaceuticals, Inc..
Rhythm Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Rhythm Pharmaceuticals, Inc..
Alternate listings
RYTM:NASDAQ
US · USD
Alternate listing for Rhythm Pharmaceuticals, Inc.; the primary context on this page is 1RV:GETTEX.
A2H5A0:LSX
DE · EUR
Alternate listing for Rhythm Pharmaceuticals, Inc.; the primary context on this page is 1RV:GETTEX.
A2H5A0:LS
DE · EUR
Alternate listing for Rhythm Pharmaceuticals, Inc.; the primary context on this page is 1RV:GETTEX.
1RV:TRADEGATE
DE · EUR
Alternate listing for Rhythm Pharmaceuticals, Inc.; the primary context on this page is 1RV:GETTEX.
RYTM:BMV
MX · MXN
Alternate listing for Rhythm Pharmaceuticals, Inc.; the primary context on this page is 1RV:GETTEX.
RYTM:BOATS
US · USD
Alternate listing for Rhythm Pharmaceuticals, Inc.; the primary context on this page is 1RV:GETTEX.
1RV:FWB
DE · EUR
Alternate listing for Rhythm Pharmaceuticals, Inc.; the primary context on this page is 1RV:GETTEX.
RYTM:BIVA
MX · MXN
Alternate listing for Rhythm Pharmaceuticals, Inc.; the primary context on this page is 1RV:GETTEX.
1RV:DUS
DE · EUR
Alternate listing for Rhythm Pharmaceuticals, Inc.; the primary context on this page is 1RV:GETTEX.
1RV:MUN
DE · EUR
Alternate listing for Rhythm Pharmaceuticals, Inc.; the primary context on this page is 1RV:GETTEX.
1RV:SWB
DE · EUR
Alternate listing for Rhythm Pharmaceuticals, Inc.; the primary context on this page is 1RV:GETTEX.